There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS – Research Report) and HealthStream (HSTM – Research Report) with bullish sentiments.
Alkermes (ALKS)
Mizuho Securities analyst Uy Ear maintained a Buy rating on Alkermes yesterday and set a price target of $37.00. The company’s shares closed last Monday at $24.43.
According to TipRanks.com, Ear is a 2-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alkermes with a $36.43 average price target, which is a 33.7% upside from current levels. In a report released today, Evercore ISI also upgraded the stock to Buy.
See today’s best-performing stocks on TipRanks >>
HealthStream (HSTM)
Craig-Hallum analyst Matt Hewitt maintained a Buy rating on HealthStream today. The company’s shares closed last Monday at $21.94.
According to TipRanks.com, Hewitt ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
HealthStream has an analyst consensus of Moderate Buy, with a price target consensus of $22.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ALKS:
